ProfileGDS4718 / 226705_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 41% 53% 88% 49% 53% 45% 58% 50% 45% 47% 48% 49% 43% 50% 47% 55% 51% 49% 65% 65% 50% 57% 43% 50% 51% 47% 53% 44% 44% 55% 45% 67% 49% 41% 58% 57% 43% 59% 48% 91% 47% 48% 74% 49% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.0511341
GSM549102patient 115, normal, homogenized [OPG study]5.7220553
GSM549104patient 119, normal, homogenized [OPG study]8.9590488
GSM549108patient 138, normal, homogenized [OPG study]5.5213749
GSM549119patient 077, normal, homogenized [OPG study]5.676253
GSM549133patient 032, cancer, homogenized [OPG study]5.1692845
GSM549139patient 042, cancer, homogenized [OPG study]5.9602758
GSM549099patient 107, normal, homogenized [OPG study]5.5130150
GSM549109patient 139, normal, homogenized [OPG study]5.258745
GSM549110patient 046, normal, homogenized [OPG study]5.3580747
GSM549114patient 063, normal, homogenized [OPG study]5.3635248
GSM549122patient 082, normal, homogenized [OPG study]5.4686249
GSM549134patient 033, cancer, homogenized [OPG study]5.1506643
GSM549136patient 036, cancer, homogenized [OPG study]5.4645650
GSM549140patient 044, cancer, homogenized [OPG study]5.3376347
GSM549111patient 047, normal, homogenized [OPG study]5.8080355
GSM549113patient 057, normal, homogenized [OPG study]5.5088151
GSM549132patient 031, cancer, homogenized [OPG study]5.4691149
GSM549137patient 038, cancer, homogenized [OPG study]6.4591465
GSM549142patient 047, cancer, homogenized [OPG study]6.4944865
GSM549100patient 110, normal, homogenized [OPG study]5.5178350
GSM549107patient 135, normal, homogenized [OPG study]5.8977757
GSM549115patient 068, normal, homogenized [OPG study]5.0878543
GSM549116patient 072, normal, homogenized [OPG study]5.504650
GSM549120patient 078, normal, homogenized [OPG study]5.5770351
GSM549131patient 030, cancer, homogenized [OPG study]5.3023647
GSM549118patient 074, normal, homogenized [OPG study]5.6810453
GSM549129patient 027, cancer, homogenized [OPG study]5.1929844
GSM549123patient 088, normal, homogenized [OPG study]5.1555344
GSM549124patient 006, cancer, homogenized [OPG study]5.820855
GSM549126patient 015, cancer, homogenized [OPG study]5.2091745
GSM549128patient 025, cancer, homogenized [OPG study]6.6603267
GSM549103patient 117, normal, homogenized [OPG study]5.4997949
GSM549117patient 073, normal, homogenized [OPG study]5.0194541
GSM549138patient 041, cancer, homogenized [OPG study]5.9693758
GSM549141patient 045, cancer, homogenized [OPG study]5.9246557
GSM549130patient 028, cancer, homogenized [OPG study]5.164343
GSM549101patient 111, normal, homogenized [OPG study]6.1064159
GSM549105patient 128, normal, homogenized [OPG study]5.4468848
GSM549106patient 134, normal, homogenized [OPG study]9.4616691
GSM549112patient 048, normal, homogenized [OPG study]5.3387447
GSM549125patient 011, cancer, homogenized [OPG study]5.3891448
GSM549127patient 024, cancer, homogenized [OPG study]7.3556974
GSM549135patient 035, cancer, homogenized [OPG study]5.4406949